Matches in SemOpenAlex for { <https://semopenalex.org/work/W2056456220> ?p ?o ?g. }
Showing items 1 to 78 of
78
with 100 items per page.
- W2056456220 endingPage "214" @default.
- W2056456220 startingPage "207" @default.
- W2056456220 abstract "OBJECTIVE Treatment with recombinant interferon-α (rIFN-α) may induce autoimmunity. We have evaluated the effect of rIFN-α on pre-existing thyroid disease with special reference to changes in TSH receptor antibody. DESIGN AND PATIENTS Five patients, who had a history of autoimmune thyroid disease diagnosed between 2 and 16 years earlier (three patients had Graves' disease while two had Hashimoto's thyroiditis), were treated with rIFN-α for chronic hepatitis C. Before, during and after rIFN-α therapy, we determined thyroid function, antithyroid antibody, thyroid echogenicity and the surface phenotype of the peripheral and intrathyroidal lymphocytes. RESULTS Four of the patients developed overt hypothyroidism after 4–7 months of rIFN-α therapy, and two of them had a preceding history of low-uptake thyrotoxicosis. Recovery of thyroid function was observed in all four patients. Strongly positive blocking type TSH receptor antibody was detected and an increase in the percentage of CD19 positive cells in the intrathyroidal lymphocytes was also observed in three of the patients even though the goitre size increased in two of them. One of the patients became thyrotoxic later when stimulating type TSH receptor antibody became positive. Another patient suffered from reversible hypothyroidism although stimulating type TSH receptor antibody remained strongly positive throughout the clinical course. CONCLUSIONS Our data thus indicated a high incidence of an unusual type of reversible hypothyroidism with TSH receptor antibodies in patients with chronic hepatitis C and pre-existing autoimmune thyroid disease after recombinant interferon-α therapy through a mechanism involving both the humoral and cellular immune systems." @default.
- W2056456220 created "2016-06-24" @default.
- W2056456220 creator A5002261325 @default.
- W2056456220 creator A5016115016 @default.
- W2056456220 creator A5016435730 @default.
- W2056456220 creator A5017771551 @default.
- W2056456220 creator A5023082545 @default.
- W2056456220 creator A5043750518 @default.
- W2056456220 creator A5079765644 @default.
- W2056456220 creator A5086430796 @default.
- W2056456220 creator A5089245225 @default.
- W2056456220 date "1996-08-01" @default.
- W2056456220 modified "2023-09-27" @default.
- W2056456220 title "Reversible primary hypothyroidism with blocking or stimulating type TSH binding inhibitor immunoglobulin following recombinant interferon-α therapy in patients with pre-existing thyroid disorders" @default.
- W2056456220 doi "https://doi.org/10.1046/j.1365-2265.1996.d01-1564.x" @default.
- W2056456220 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8881454" @default.
- W2056456220 hasPublicationYear "1996" @default.
- W2056456220 type Work @default.
- W2056456220 sameAs 2056456220 @default.
- W2056456220 citedByCount "18" @default.
- W2056456220 crossrefType "journal-article" @default.
- W2056456220 hasAuthorship W2056456220A5002261325 @default.
- W2056456220 hasAuthorship W2056456220A5016115016 @default.
- W2056456220 hasAuthorship W2056456220A5016435730 @default.
- W2056456220 hasAuthorship W2056456220A5017771551 @default.
- W2056456220 hasAuthorship W2056456220A5023082545 @default.
- W2056456220 hasAuthorship W2056456220A5043750518 @default.
- W2056456220 hasAuthorship W2056456220A5079765644 @default.
- W2056456220 hasAuthorship W2056456220A5086430796 @default.
- W2056456220 hasAuthorship W2056456220A5089245225 @default.
- W2056456220 hasConcept C126322002 @default.
- W2056456220 hasConcept C134018914 @default.
- W2056456220 hasConcept C159654299 @default.
- W2056456220 hasConcept C163764329 @default.
- W2056456220 hasConcept C170493617 @default.
- W2056456220 hasConcept C203014093 @default.
- W2056456220 hasConcept C2776652619 @default.
- W2056456220 hasConcept C2778696486 @default.
- W2056456220 hasConcept C2993291352 @default.
- W2056456220 hasConcept C45121317 @default.
- W2056456220 hasConcept C50181227 @default.
- W2056456220 hasConcept C526584372 @default.
- W2056456220 hasConcept C71924100 @default.
- W2056456220 hasConceptScore W2056456220C126322002 @default.
- W2056456220 hasConceptScore W2056456220C134018914 @default.
- W2056456220 hasConceptScore W2056456220C159654299 @default.
- W2056456220 hasConceptScore W2056456220C163764329 @default.
- W2056456220 hasConceptScore W2056456220C170493617 @default.
- W2056456220 hasConceptScore W2056456220C203014093 @default.
- W2056456220 hasConceptScore W2056456220C2776652619 @default.
- W2056456220 hasConceptScore W2056456220C2778696486 @default.
- W2056456220 hasConceptScore W2056456220C2993291352 @default.
- W2056456220 hasConceptScore W2056456220C45121317 @default.
- W2056456220 hasConceptScore W2056456220C50181227 @default.
- W2056456220 hasConceptScore W2056456220C526584372 @default.
- W2056456220 hasConceptScore W2056456220C71924100 @default.
- W2056456220 hasIssue "2" @default.
- W2056456220 hasLocation W20564562201 @default.
- W2056456220 hasLocation W20564562202 @default.
- W2056456220 hasOpenAccess W2056456220 @default.
- W2056456220 hasPrimaryLocation W20564562201 @default.
- W2056456220 hasRelatedWork W1989571854 @default.
- W2056456220 hasRelatedWork W2012306679 @default.
- W2056456220 hasRelatedWork W2017676244 @default.
- W2056456220 hasRelatedWork W2051773936 @default.
- W2056456220 hasRelatedWork W2093507502 @default.
- W2056456220 hasRelatedWork W2096357133 @default.
- W2056456220 hasRelatedWork W2399738046 @default.
- W2056456220 hasRelatedWork W2424317111 @default.
- W2056456220 hasRelatedWork W2890456764 @default.
- W2056456220 hasRelatedWork W3092808699 @default.
- W2056456220 hasVolume "45" @default.
- W2056456220 isParatext "false" @default.
- W2056456220 isRetracted "false" @default.
- W2056456220 magId "2056456220" @default.
- W2056456220 workType "article" @default.